Palaniappan M
Biomedicines. 2025; 12(12.
PMID: 39767607
PMC: 11673253.
DOI: 10.3390/biomedicines12122700.
Guclu-Geyik F, Erginel T, Gulec C, Koseoglu-Buyukkaya P, Erginel-Unaltuna N
Mol Biol Rep. 2024; 51(1):1144.
PMID: 39531130
DOI: 10.1007/s11033-024-10091-w.
Chen Y, Anderson M, Payne N, Santori F, Ivanova N
Cells. 2024; 13(15.
PMID: 39120315
PMC: 11311682.
DOI: 10.3390/cells13151284.
Szabo F, Koves K, Gal L
Int J Mol Sci. 2024; 25(12).
PMID: 38928237
PMC: 11203711.
DOI: 10.3390/ijms25126531.
Hablase R, Kyrou I, Randeva H, Karteris E, Chatterjee J
Cancers (Basel). 2024; 16(11).
PMID: 38893278
PMC: 11172073.
DOI: 10.3390/cancers16112160.
Editorial: Advances in molecular classification and targeting of solid tumors.
Pandey M, Kumar T, Koshiol J
Front Oncol. 2024; 14:1373599.
PMID: 38414742
PMC: 10896838.
DOI: 10.3389/fonc.2024.1373599.
Evaluation Factors Affecting on Recurrence, Metastasis, and Survival of Breast Cancer in Iranian Women by Multi-State Model Approach.
Mousavi M, Hajizadeh E, Rasekhi A, Haghighat S
Iran J Public Health. 2023; 52(10):2186-2195.
PMID: 37899919
PMC: 10612554.
DOI: 10.18502/ijph.v52i10.13857.
Estrogen Receptor Signaling in Breast Cancer.
Miziak P, Baran M, Blaszczak E, Przybyszewska-Podstawka A, Kalafut J, Smok-Kalwat J
Cancers (Basel). 2023; 15(19).
PMID: 37835383
PMC: 10572081.
DOI: 10.3390/cancers15194689.
Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases.
Visniauskas B, Kilanowski-Doroh I, Ogola B, McNally A, Horton A, Imulinde Sugi A
J Hum Hypertens. 2022; 37(8):609-618.
PMID: 36319856
PMC: 10919324.
DOI: 10.1038/s41371-022-00771-0.
Potential therapeutic targets for age-related macular degeneration: The nuclear option.
Choudhary M, Malek G
Prog Retin Eye Res. 2022; 94:101130.
PMID: 36220751
PMC: 10082136.
DOI: 10.1016/j.preteyeres.2022.101130.
Importins involved in the nuclear transportation of steroid hormone receptors: and data.
Kalyvianaki K, Panagiotopoulos A, Patentalaki M, Castanas E, Kampa M
Front Endocrinol (Lausanne). 2022; 13:954629.
PMID: 36147566
PMC: 9487861.
DOI: 10.3389/fendo.2022.954629.
Estrogen Receptor Alpha and ESR1 Mutations in Breast Cancer.
Patel J, Jeselsohn R
Adv Exp Med Biol. 2022; 1390:171-194.
PMID: 36107319
DOI: 10.1007/978-3-031-11836-4_10.
GRHL2 Enhances Phosphorylated Estrogen Receptor (ER) Chromatin Binding and Regulates ER-Mediated Transcriptional Activation and Repression.
Reese R, Helzer K, Allen K, Zheng C, Solodin N, Alarid E
Mol Cell Biol. 2022; 42(10):e0019122.
PMID: 36036613
PMC: 9584124.
DOI: 10.1128/mcb.00191-22.
Differential Effects of the G-Protein-Coupled Estrogen Receptor (GPER) on Rat Embryonic (E18) Hippocampal and Cortical Neurons.
Pemberton K, Rosato M, Dedert C, DeLeon C, Arnatt C, Xu F
eNeuro. 2022; 9(4).
PMID: 35788105
PMC: 9291730.
DOI: 10.1523/ENEURO.0475-21.2022.
Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions.
Farkas S, Szabo A, Hegyi A, Torok B, Fazekas C, Ernszt D
Biomedicines. 2022; 10(4).
PMID: 35453610
PMC: 9029610.
DOI: 10.3390/biomedicines10040861.
Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors.
Dalal H, Dahlgren M, Gladchuk S, Brueffer C, Gruvberger-Saal S, Saal L
Sci Rep. 2022; 12(1):4696.
PMID: 35304506
PMC: 8933558.
DOI: 10.1038/s41598-022-08210-3.
Estrogenic Action in Stress-Induced Neuroendocrine Regulation of Energy Homeostasis.
Krolick K, Shi H
Cells. 2022; 11(5).
PMID: 35269500
PMC: 8909319.
DOI: 10.3390/cells11050879.
Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis.
Porras L, Ismail H, Mader S
Cells. 2021; 10(11).
PMID: 34831189
PMC: 8616513.
DOI: 10.3390/cells10112966.
Nuclear receptors: from molecular mechanisms to therapeutics.
Frigo D, Bondesson M, Williams C
Essays Biochem. 2021; 65(6):847-856.
PMID: 34825698
PMC: 8628184.
DOI: 10.1042/EBC20210020.
Nuclear Receptors and Clock Components in Cardiovascular Diseases.
Pourcet B, Duez H
Int J Mol Sci. 2021; 22(18).
PMID: 34575881
PMC: 8468608.
DOI: 10.3390/ijms22189721.